Skip to content

Corticosteroid injection combined with extracoporeal shockwave therapy in elbow pain

MRI and Ultra sound analysis of Corticosteroid injection combined with extracoporeal shockwave therapy in Lateral epicondylitis - A prospective, randomised, double - blinded, placebo controlled trial.

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024730
Enrollment
60
Registered
2020-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M248- Other specific joint derangements,not elsewhere classified

Interventions

Intervention1: Carticosteroid injection with Shockwave therapy: 1 ml Triamcinolone Acetonide (10 mg/ml) (Kenacort- A 10) with 1 ml Lignocaine (1%) [Corticosteroid injection] will be administered into

Sponsors

Prince Sattam Bin Abdulaziz University Al Kharj Saudi Arabia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 18 â?? 60 years with pain over lateral humeral epicondyle, unilateral elbow pain for more than 2 months with pain intensity in VAS scale between 4 and 8 mm and willing to participate for the treatment and further follow up program will be included.

Exclusion criteria

Exclusion criteria: Participants with prior steroid injection therapy, associated neck or arm pain, severe musculoskeletal, neural, somatic and psychiatric conditions, waiting for surgery, having alcohol or drug abuse, involving in other weight training programs were excluded from the study. Participants with other soft tissue injuries, fracture at the limbs, deformities were also excluded from the study.

Design outcomes

Primary

MeasureTime frame
1. MRI analysis - Common extensor tendon injury 2. Ultra sound analysi - Common extensor tendon injury 3. Pain intensity â?? VAS 3. Functional disability - Patient rated tennis elbow evaluation 4. Hand grip â?? Hand dynamometer Timepoint: Baseline, after 4 weeks, 8 weeks and 6 months

Secondary

MeasureTime frame
1. Patient perception â?? Global impression of change 2. Kinesiophobia â?? Tampa scale 3. Depression â?? Hospital anxiety and depression scale 4. Quality of life â?? Euro Qol EQ-5D Timepoint: Baseline, after 4 weeks, 8 weeks and 6 months

Countries

Saudi Arabia

Contacts

Public ContactGopal Nambi

Prince Sattam Bin Abdulaziz University

physio_gopal@rediffmail.com00966501878382

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026